Company Analysis Fuso Pharmaceutical Industries,Ltd.
1. Summary
Advantages
- Dividends (4.97%) are higher than the sector average (2.69%).
- The stock's return over the last year (18.1%) is higher than the sector average (0.1167%).
- Current debt level 16.78% is below 100% and has decreased over 5 years from 23.71%.
- The company's current efficiency (ROE=3.81%) is higher than the sector average (ROE=-9.9%)
Disadvantages
- Price (2596 Β₯) is higher than fair price (2118.02 Β₯)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Fuso Pharmaceutical Industries,Ltd. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.8% | 0% | -5.3% |
| 90 days | 1.9% | 0% | -10.7% |
| 1 year | 18.1% | 0.1% | -11.3% |
4538 vs Sector: Fuso Pharmaceutical Industries,Ltd. has outperformed the "Healthcare" sector by 17.99% over the past year.
4538 vs Market: Fuso Pharmaceutical Industries,Ltd. has outperformed the market by 29.43% over the past year.
Stable price: 4538 is not significantly more volatile than the rest of the market on "Tokyo Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 4538 with weekly volatility of 0.3481% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (2596 Β₯) is higher than the fair price (2118.02 Β₯).
Price is higher than fair: The current price (2596 Β₯) is 18.4% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (14.5) is lower than that of the sector as a whole (111.01).
P/E vs Market: The company's P/E (14.5) is lower than that of the market as a whole (135.14).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.5447) is lower than that of the sector as a whole (70.26).
P/BV vs Market: The company's P/BV (0.5447) is lower than that of the market as a whole (103.82).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.3604) is lower than that of the sector as a whole (74.99).
P/S vs Market: The company's P/S indicator (0.3604) is lower than that of the market as a whole (104.62).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (7.51) is lower than that of the sector as a whole (17.9).
EV/Ebitda vs Market: The company's EV/Ebitda (7.51) is lower than that of the market as a whole (112.15).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 18.95% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (18.95%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-5.23%).
5.4. ROE
ROE vs Sector: The company's ROE (3.81%) is higher than that of the sector as a whole (-9.9%).
ROE vs Market: The company's ROE (3.81%) is lower than that of the market as a whole (8.46%).
5.5. ROA
ROA vs Sector: The company's ROA (1.86%) is higher than that of the sector as a whole (-10.11%).
ROA vs Market: The company's ROA (1.86%) is lower than that of the market as a whole (3.74%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (4.66%) is lower than that of the sector as a whole (9.09%).
ROIC vs Market: The company's ROIC (4.66%) is lower than that of the market as a whole (8.77%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 4.97% is higher than the average for the sector '2.69%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 4.97% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 4.97% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (46.84%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
